OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
ACHP President and CEO Ceci Connolly coauthored an op-ed examining if the obesity epidemic could be solved with free GLP-1s.
Tag: prescription drugs / drug prices
ACHP Calls for Hearings on High-Cost Cell and Gene Therapies
ACHP sent a letter to key Congressional committee leaders urging hearings on the high-cost cell and gene therapies rapidly gaining FDA approval.
A Cautionary Tale: The Rise of GLP-1s
This brief underscores the history of GLP-1 medications and makes policy recommendations to ensure patients are receiving the right drugs at the right time.
Medicare Advantage: The Choice of America’s Seniors
By offering lower costs, more benefits and better outcomes, Medicare Advantage is increasingly becoming the Choice of America’s Seniors.
ACHP Statement on CY 2025 Advance Notice for Medicare Advantage and Part D
ACHP issued a statement in response to CMS’ CY 2025 Advance Notice for Medicare Advantage and Part D.
